Preclinical safety profile of disitamab vedotin：a novel anti-HER2 antibody conjugated with MMAE-Reference-Cited by-同舟云学术

Preclinical safety profile of disitamab vedotin：a novel anti-HER2 antibody conjugated with MMAE

Published:2020-05 Issue: Volume:324 Page:30-37
ISSN:0378-4274
Container-title:Toxicology Letters
language:en
Short-container-title:Toxicology Letters

Author:

Jiang Jing,Li Shenjun,Shan Xiaolei,Wang Ling,Ma Jinling,Huang Min,Dong Lihou,Chen Fang

Funder

National Science and Technology Major Project of China

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference19 articles.

1. An integrated approach to identify normal tissue expression of targets for antibody-drug conjugates: case study of TENB2;Boswell;Br. J. Pharmacol.,2013

2. OVEREXPRESSION OF THE c-erbB-2 ONCOPROTEIN IN HUMAN BREAST CARCINOMAS: IMMUNOHISTOLOGICAL ASSESSMENT CORRELATES WITH GENE AMPLIFICATION;VENTER;THE LANCET JULY,1987

3. Antibody-drug conjugates: Pharmacokinetic/Pharmacodynamic modeling, preclinical characterization, clinical studies, and lessons learned;Hedrich;Clin. Pharmacokinet.,2018

4. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors;Klapper;Adv. Cancer Res.,2000

5. [Non-small cell lung cancer: HER2 oncogene status];Kobyakov;Arkh. Patol.,2015

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody Drug Conjugates for Cancer Therapy: From Metallodrugs to Nature-Inspired Payloads;International Journal of Molecular Sciences;2024-08-08

2. Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers;Hematology/Oncology Clinics of North America;2024-06

3. State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies;Current Opinion in Oncology;2024-05-01

4. Development and validation of bioanalytical methods to support clinical study of disitamab vedotin;Bioanalysis;2024-03-26

5. A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers;Molecular Cancer;2024-03-23